GENE ONLINE|News &
Opinion
Blog

2020-02-26| Asia-Pacific

Company Presentations at BIO Asia-Taiwan 2020 Now Accepting Applications

by GeneOnline
Share To

With the roaring success in 2019, the BIO Asia-Taiwan International Conference and Exhibition, co-organized by Biotechnology Innovation Organization (BIO) and Taiwan Bio Industry Organization (Taiwan BIO), is once again welcoming biomedical disciplines and industries to participate in one of the largest gatherings in the Asia Pacific region in July 2020 at the newly constructed Taipei Nangang Exhibition Center, Hall 2.

The five-day BIO Asia-Taiwan International Conference and Exhibition offers a packed schedule of events, including exhibitions, company presentations, BIO One-on-One Partnering™ meetings, seminars, workshops, and social gatherings from July 22nd to July 26th, 2020 in Taipei, Taiwan.

With 1700 booths from 650 exhibitors expected, not only the exhibitors will have the opportunity to showcase their companies, innovations, products, or services during the four-day exhibition to investors and professionals, all attendees will also have the chance to engage with global companies and stay ahead of the latest trends in biopharmaceutical, precision medicines, smart medical, and medical devices, etc..

Whether you are a venture capital firm, a start-up entrepreneur, or a well-established company, the Company Presentations session will provide the advantages of making a more direct connection and increase visibility with a richly-targeted audience of global investors, deal-making partners, and future customers, participating company can also maximize meeting efficiency by levering the BIO One-on-One Partnering™ system, an easy-to-use online meeting scheduling system to search for and identify potential partners, collaborators, investors and in- and out-licensing opportunities. With over 2,000 face-to-face meetings made via the system during BIO Asia–Taiwan 2019, we expect over 3,500 meetings to be successfully scheduled during the 2020 event.

Company Presentations is now accepting applications till March 31st, learn more at 2020 Company Presentations.

 

©www.geneonline.com All rights reserved. Collaborate with us: service@geneonlineasia.com
Related Post
BIO Asia-Taiwan 2022: Looking for the Exit; Startup Considerations and Strategies
2022-07-28
BIO Asia-Taiwan 2022: Top iPS Cell Technologies at Affordable Prices – Keynote by Nobel Laureate Shinya Yamanaka
2022-07-28
Reinvigorating the Asian Biomedical Ecosystem With BIO Asia-Taiwan 2022
2022-07-26
LATEST
Rebyota Passes Through FDA To Become First Approved Fecal Microbiota Product
2022-12-05
RemeGen Presented New Data Updates on Telitacicept for SLE and primary Sjogren’s syndrome at ACR Convergence 2022
2022-12-05
EMA Urges Pholcodine’s Removal from European Market Following Safety Study
2022-12-05
Lynk Pharmaceuticals Announces First Patient Dosed in Phase Ⅱ Clinical Study of LNK01003 in Patients with Ulcerative Colitis
2022-12-04
Cure Brain Cancer Foundation Rings Nasdaq Opening Bell, Announces U.S. Expansion
2022-12-02
Focus-X Therapeutics, a Viva Biotech Portfolio Company, Successfully Reached an Acquisition Agreement with Full-Life Technologies
2022-12-02
Pfizer To Invest $1.26 Billion In Irish Plant, Forms New Vant Company Targeting Inflammation
2022-12-02
EVENT
2022-12-10
64TH ASH ANNUAL MEETING & EXPOSITION
New Orleans, USA
2022-12-14
BIOHK2022
Hong Kong, China
2022-12-21
Avatar Medicine Forum
Online
2023-01-07
7th Asia Microbiome Conference
Taipei, Taiwan
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!